Elanco Animal Health Research and Development Expenses 2016-2024 | ELAN

Elanco Animal Health annual/quarterly research and development expenses history and growth rate from 2016 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Elanco Animal Health research and development expenses for the quarter ending December 31, 2024 were $0.081B, a 2.53% increase year-over-year.
  • Elanco Animal Health research and development expenses for the twelve months ending December 31, 2024 were $344M, a 5.2% increase year-over-year.
  • Elanco Animal Health annual research and development expenses for 2024 were $0.344B, a 5.2% increase from 2023.
  • Elanco Animal Health annual research and development expenses for 2023 were $0.327B, a 1.87% increase from 2022.
  • Elanco Animal Health annual research and development expenses for 2022 were $0.321B, a 13.01% decline from 2021.
Elanco Animal Health Annual Research and Development Expenses
(Millions of US $)
2024 $344
2023 $327
2022 $321
2021 $369
2020 $329
2019 $270
2018 $247
2017 $252
2016 $266
2015 $291
Elanco Animal Health Quarterly Research and Development Expenses
(Millions of US $)
2024-12-31 $81
2024-09-30 $87
2024-06-30 $89
2024-03-31 $87
2023-12-31 $79
2023-09-30 $86
2023-06-30 $81
2023-03-31 $81
2022-12-31 $80
2022-09-30 $78
2022-06-30 $82
2022-03-31 $81
2021-12-31 $92
2021-09-30 $94
2021-06-30 $94
2021-03-31 $89
2020-12-31 $115
2020-09-30 $88
2020-06-30 $59
2020-03-31 $67
2019-12-31 $67
2019-09-30 $70
2019-06-30 $69
2019-03-31 $64
2018-12-31 $61
2018-09-30 $59
2018-06-30 $61
2018-03-31 $65
2017-12-31
2017-09-30 $62
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $5.492B $4.417B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.804B 0.00
Quest Diagnostics (DGX) United States $19.317B 19.51
DaVita (DVA) United States $11.363B 14.49
Encompass Health (EHC) United States $9.962B 22.32
Chemed (CHE) United States $8.236B 25.31
Option Care Health (OPCH) United States $5.459B 25.87
RadNet (RDNT) United States $4.453B 98.62
Amedisys (AMED) United States $2.998B 21.34
LifeStance Health (LFST) United States $2.904B 0.00
Addus HomeCare (ADUS) United States $1.974B 22.91
Astrana Health (ASTH) United States $1.946B 26.61
U.S Physical Therapy (USPH) United States $1.298B 34.13
Pennant (PNTG) United States $0.864B 34.93
Aveanna Healthcare Holdings (AVAH) United States $0.799B 0.00
Atai Life Sciences (ATAI) Germany $0.305B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00